Shanghai Pharmaceuticals Holding Co Ltd (601607.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Distributors · China · ISIN CNE000000C82

Price
16.84 CNY
Market cap
62.45 bn CNY
P/E (2025)
–
P/S (2025)
0.22
Dividend yield
3.38 %
Net margin
2.02 %
Return on equity (ROE)
6.38 %
Return on assets (ROA)
2.46 %

Shanghai Pharmaceuticals Holding Co Ltd financials

Fiscal year20242025
Revenue275.25 bn CNY283.58 bn CNY
Gross profit30.41 bn CNY30.42 bn CNY
Operating income8.14 bn CNY9.28 bn CNY
EBIT8.75 bn CNY11.51 bn CNY
Net income4.55 bn CNY5.72 bn CNY

Full history since 1993, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shanghai Pharmaceuticals Holding Co Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.

Shanghai Pharmaceuticals Holding Co Ltd stock (601607.SS): P/E, revenue, dividend | finmetric